Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 1, 2001Annals of the New York Academy of Sciences

Gene Therapy for Cardiovascular Disorders

View Full Paper
Ask AI
Bookmark
Share

Authors

BMBeverly L. MetcalfeAmerican Association of Colleges of PharmacyKSKathleen W. SellersUniversity of FloridaMHMatthew J. HuentelmanAlzheimer's Association

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Metcalfe et al. (2001) studied this question.

synapsesocial.com/papers/6a91635deb80182e01120bcahttps://doi.org/10.1111/j.1749-6632.2001.tb11358.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Decoy Administration of NF- κ B into the Subarachnoid Space for Cerebral Angiopathy1998 · 73 citations
  2. 2Adrenomedullin Gene Delivery Attenuates Hypertension, Cardiac Remodeling, and Renal Injury in Deoxycorticosterone Acetate-Salt Hypertensive Rats2000 · 120 citations
  3. 3Development of lentiviral vectors for gene therapy for human diseases2000 · 242 citations
  4. 4Adenoviral Expression of a Urokinase Receptor–Targeted Protease Inhibitor Inhibits Neointima Formation in Murine and Human Blood Vessels2001 · 61 citations
  5. 5Gene therapy to promote thromboresistance: Local overexpression of tissue plasminogen activator to prevent arterial thrombosis in an in vivo rabbit model1999 · 68 citations